Application of Biomarkers in Neurological Diseases
ConditionBiomarkers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorYi Yang
About this trial
To explore the predictive and diagnostic role of biomarkers in patients with neurological diseases.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients with neurological diseases;
Subjects or legal agents agree to participate in the study and sign the informed consent.
Disqualifiers
Participating in other clinical investigators;
Unwilling to be followed up or poor treatment compliance;
Other conditions considered unsuitable for inclusion by the researchers.
Trial population
Patients with neurological diseases admitted to hospital/emergency department.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
3,000 Participants
are grouped into 1 trial groupGroup A: Patients admitted to hospital/emergency department with neurological diseases
Trial outcomes
Primary outcomes
1
mRS score in 90 days
The proportion of 3-month good functional outcome (mRS Score 0-2) in patients with neurological diseases was evaluated by mRS Score
Time frame
3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Yi Yang
Lead sponsor
The First Hospital of Jilin University
Sponsor institution
Source ClinicalTrials.gov